SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-19-000047
Filing Date
2019-05-14
Accepted
2019-05-14 16:03:43
Documents
5
Period of Report
2019-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningscall33119.htm 8-K 26200
2 EXHIBIT 99.1 a3318272releasepreviewpd.htm EX-99.1 16547
3 a3318272releasepreviewpd001.jpg GRAPHIC 271090
4 a3318272releasepreviewpd002.jpg GRAPHIC 299569
5 a3318272releasepreviewpd003.jpg GRAPHIC 83886
  Complete submission text file 0001401914-19-000047.txt   945919
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 19822663
SIC: 2834 Pharmaceutical Preparations